|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | |
| C12Q 1/68 | |||
| A61K 39/00 | |||
| C12Q 1/6883 |
| (11) | Patento numeris | 3004172 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14739600.6 |
| Europos patento paraiškos padavimo data | 2014-05-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/040050 |
| Data | 2014-05-29 |
| (87) | Numeris | WO 2014/194111 |
| Data | 2014-12-04 |
| (30) | Numeris | Data | Šalis |
| 201361828730 P | 2013-05-30 | US | |
| 201361889553 P | 2013-10-11 | US | |
| 201361901212 P | 2013-11-07 | US |
| (72) |
SWERGOLD, Gary, US
MELLIS, Scott, US
SASIELA, William, J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS |
| METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS |